Logo for EpiBone

Meet an Unreasonable Venture


Creating bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.

Photo of Nina Tandon

Nina Tandon

CEO & Co-Founder at EpiBone

More about Nina »
Employees 21–50
Headquarters Jersey City, New Jersey, United States
EpiBone, Inc. is privately-held clinical-stage regenerative medicine company focused on skeletal reconstruction. Sitting at the intersection of biology and engineering, the company harnesses the power of cells to create living solutions that can become a seamless part of a patient’s body. EpiBone is currently developing a pipeline of bone, cartilage, and compound (bone and cartilage) products.

Currently Operating in One Region

Press Mentions

July 24, 2023

EpiBone to Start Clinical Trials for Knee Cartilage Grown in Lab

Read on PRNewswire »

October 25, 2023

Behind Nina Tandon — The Big Apple and the Biotech Founder

Read on Brown Girl Magazine »

March 9, 2023

EpiBone, emerging biotech company, is relocating to Jersey City — and bringing nearly 100 jobs | ROI-NJ

Read on ROI-NJ »

October 17, 2015

Why Peter Thiel Invested In New York Biotech Startup EpiBone

Read on Inc.com »

More Ventures in Health

Get the Unreasonable Newsletter

Get monthly updates on EpiBone and over 386 other ventures working to solve the world's toughest problems.

Read our Privacy Policy.